ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 64 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $7,523,000 | -52.7% | 140,756 | 0.0% | 6.53% | -32.0% |
| Q4 2015 | $15,901,000 | -88.5% | 140,756 | -88.1% | 9.61% | -73.0% |
| Q3 2015 | $138,718,000 | +52.0% | 1,178,474 | 0.0% | 35.56% | +38.2% |
| Q2 2015 | $91,249,000 | +33.8% | 1,178,474 | 0.0% | 25.74% | +64.0% |
| Q1 2015 | $68,175,000 | +79.4% | 1,178,474 | 0.0% | 15.70% | +50.1% |
| Q4 2014 | $38,006,000 | +31.8% | 1,178,474 | 0.0% | 10.46% | -19.3% |
| Q3 2014 | $28,837,000 | +5.2% | 1,178,474 | -23.8% | 12.96% | -11.5% |
| Q2 2014 | $27,411,000 | -11.4% | 1,545,999 | 0.0% | 14.65% | -8.9% |
| Q1 2014 | $30,935,000 | +19.2% | 1,545,999 | 0.0% | 16.08% | +15.2% |
| Q4 2013 | $25,942,000 | +51.6% | 1,545,999 | -4.0% | 13.96% | +47.8% |
| Q3 2013 | $17,107,000 | +90.0% | 1,610,856 | 0.0% | 9.45% | +41.3% |
| Q2 2013 | $9,005,000 | – | 1,610,856 | – | 6.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |